Cardiac autophagy deficiency attenuates ANP production and disrupts myocardial-adipose crosstalk leading to increased fat accumulation and metabolic dysfunction
posted on 2020-10-12, 21:02authored byAda AdminAda Admin, Erfei Song, Daniel Da Eira, Shailee Jani, Diane Sepa-Kishi, Vivian Vu, Howard Hunter, Mi Lai, Michael B. Wheeler, Rolando B. Ceddia, Gary Sweeney
Increased myocardial
autophagy has been established as an important stress-induced cardioprotective
response. Three weeks after generating cardiomyocyte-specific autophagy
deficiency, via inducible deletion of autophagy related protein 7 (Atg7), we
found these mice (AKO) increased body weight and fat mass without altered food
intake. Glucose and insulin tolerance tests indicated reduced insulin
sensitivity in AKO mice. Metabolic cage analysis showed reduced ambulatory activity
and oxygen consumption with a trend of elevated respiratory exchange ratio in
AKO mice. Direct analysis of metabolism in subcutaneous and visceral adipocytes
showed increased glucose oxidation and reduced ATGL expression and HSL
phosphorylation with no change in lipid synthesis or fatty acid oxidation. Importantly,
we found AKO mice had reduced myocardial and circulating levels of atrial
natriuretic peptide (ANP), an established mediator of myocardial-adipose
crosstalk. When normal ANP levels were restored to AKO mice using osmotic pump,
the metabolic dysfunction evident in AKO mice was corrected. We conclude that
cardiac autophagy deficiency alters myocardial-adipose crosstalk via decreased
ANP levels with adverse metabolic consequences.
Funding
This work was supported by an operating grant to GS from Canadian Institutes of Health Research, to ES from National Natural Science Foundation of China to SEF (81900779) and to RBC from National Science and Engineering Research Council. GS also gratefully acknowledges support from Heart & Stroke Foundation of Ontario via a Career Investigator Award.